Hers vs Ro: Which GLP-1 Provider Is Better?
Short answer: Hers and Ro tie at 7.3/10 on our rubric, so the decision comes down to price and format rather than overall quality. Full reasoning, pricing and the cases where the other one wins are below.
Hers edges Ro on our rubric, 7.3 to 7.2, a margin narrow enough that we treat it as a tie. The score will not decide this for you. Three concrete differences will: Ro bills insurance and Hers takes none, Ro sells only FDA-approved brand medication while Hers also sells compounded semaglutide and tirzepatide, and both now require a membership on top of medication. Their lowest $149 medication path starts at $188 in month one and $298/mo ongoing; exact product and dose prices vary.
Disclosure: Hers pays us a commission when you sign up through our links. Ro pays us nothing. Both are scored by the same published methodology, and where Ro is the better buy, this page says so. How we make money.
A side-by-side look at Hers and Ro to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#30 of 54The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit HersRo
#38 of 54One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.
Visit Ro| Feature | Hers | Ro |
|---|---|---|
| Why each one | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. | The most trusted name in telehealth with the fastest prescription turnaround, same-day approval is standard, not the exception. |
| Our Score | 7.3/10 | 7.2/10 |
| Headline Price | $188 first month, then $298/mo | $149/mo membership + medication |
| Medication Type | Both | Brand |
| Insurance Accepted | No | Yes |
| Best For | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path | Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing |
| Watch out for | Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings. | Membership and medication are billed separately, readers need to add them together for the all-in monthly cost |
| Ranking | #30 | #38 |
| Get started | Visit Hers | Visit Ro |
Pros & Cons Compared
Hers
Pros
- +FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Ro
Pros
- +Carries Foundayo (orforglipron), Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026, at $149-$349 depending on dose and refill timing via LillyDirect matching
- +Direct insurance billing with major carriers, with coverage, Wegovy or Zepbound can cost $0-25/mo copay
- +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
- +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx, some of the lowest cash brand prices available
Cons
- −Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
- −Brand-name only, no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
- −Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)
Where Ro wins
Insurance on Zepbound. Ro lists medication at $299-449/mo by dose, or $448-598/mo ongoing after its $149 membership, and it can bill major carriers. Hers lists Zepbound medication from $299 plus the same $39-first-month/$149-ongoing membership structure, so its listed floor is $338 initially and $448/mo ongoing before dose changes. The cash floors overlap; Ro's advantage is insurance handling, not a categorical lower cash price.
Insurance. Ro bills major carriers directly, and with coverage brand Wegovy or Zepbound can come down to a $0-25/mo copay. Hers takes no insurance at all; every Hers price is cash.
FDA approval across the whole menu. Ro is brand name only: Wegovy as an injection or an oral pill, Zepbound, and Eli Lilly's Foundayo, an FDA approved oral GLP-1 that launched April 6, 2026. Hers sells compounded semaglutide and compounded tirzepatide alongside its brand options, and compounded medications are not FDA approved. If you want everything you might be prescribed to carry FDA approval, Ro is the more conservative choice.
Third party reviews, narrowly. Ro's Trustpilot sits at 3.9/5 across 5,086 reviews against 3.4/5 across 5,700 for Hers.
Where Hers wins
Compounded options exist at all. Hers lists compounded semaglutide medication at $199/mo and compounded tirzepatide medication at $199-299/mo; Ro sells neither. With Hers' required membership, a $199 medication path totals $238 in month one and $348/mo ongoing, while a $299 medication path totals $338 initially and $448/mo ongoing. Compounded finished products are not FDA approved.
A broader women's-health platform. On price, the lowest Wegovy-pill path is a tie: Hers and Ro each list $149 medication plus a $39 first-month/$149 ongoing membership, or $188 initially and $298/mo ongoing before product- or dose-specific increases. Hers folds weight management into a wider platform covering hormonal, skin, and wellness care.
What to know before you pick either
Before you pick Hers, two things from our own file. The FDA called Hers' compounded semaglutide marketing “false or misleading”, and complaint site sentiment skews negative on operations: PissedConsumer rates it 1.8/5, with recurring reports of unauthorized charges, hard to cancel subscriptions, and refused refunds. Ro's complaint pattern is different in kind. Reddit users there tend to praise the weight loss results and the drop in food noise, and push back on the separately billed $149/mo membership, cancellation friction, and refund handling. Neither company has a clean file. Decide which complaint you would rather risk living with.
Hers vs Ro: common questions
Is Ro or Hers better for Zepbound?
Ro if you need insurance billed; the listed cash floors overlap. Ro lists Zepbound medication at $299-449/mo by dose plus membership, while Hers lists it from $299 plus the same $39 first-month/$149 ongoing membership structure. That puts each starter path at $338 initially and $448/mo ongoing before dose changes. Ro can bill insurance and Hers cannot.
Is Ro or Hers better for the Wegovy pill?
Both carry the FDA-approved Wegovy pill. Each lists medication from $149 with a $39 first-month and $149/mo ongoing membership, so the cash floor is $188 initially and $298/mo ongoing before dose changes. Ro can bill insurance, and with coverage the medication copay may be lower; Hers is cash-pay only. Confirm the prescribed dose and every checkout line item.
Does Ro or Hers take insurance?
Ro does, Hers does not. Ro bills major carriers directly, and with coverage brand Wegovy or Zepbound can cost $0-25/mo in copay on top of the $149/mo Ro Body membership. At Hers, every price is cash pay.
Is Ro or Hers better for GLP-1 weight loss overall?
Our rubric puts Hers at 7.3 and Ro at 7.2, close enough that we treat it as a tie. Pick Ro if you want insurance billed directly or an all-brand menu. Pick Hers if you want compounded semaglutide or tirzepatide, which it lists from $199 for medication plus the required membership. On the lowest $149 brand-medication path, both start at $188 in month one and $298/mo ongoing. Compounded finished products are not FDA approved, and FDA has criticized Hers' compounded-semaglutide marketing.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Hers and Ro.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Hers vs Mochi Healthfrom $178/mo
- Hers vs Hims$188 first month, then $298/mo
- Hers vs GoodRx Care$119/mo subscription + medication
- Ro vs Noom Med$79 first month, then $199/mo
- Ro vs GobyMedsfrom $99/mo
- Ro vs WeightWatchers (Sequence)$74/mo membership + medication
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.